IRCT20170211032494N2已完成3 期
Efficacy of Duloxetine for the prevention of Oxaliplatin Induced Peripheral Nephropathy (OIPN)- A double blinded placebo controlled phase 2 study
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Patients have pathologically confirmed cancer; Aged 18-75; Candidate for receiving at least 4 courses of Oxaliplatin; Good performance status (based on ECOG)
排除标准
- •History of diabetes mellitus; Previous neuropathy; Chronic renal or liver disease; Consumption of neurotoxic/neurotropic/neuroleptic drugs
研究者
相似试验
进行中（未招募）
2 期
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerNCT04137107Alliance for Clinical Trials in Oncology220
已完成
2 期
efficacy of Duloxetine for prevention of chemotherapy induced neuropathybreast cancer.Malignant neoplasm of breastIRCT2016050227711N1Breast Cancer Research Center of Jahad Daneshgahi116
招募中
3 期
Evaluation of Duloxetine effect on Oxaliplatin induced peripheral neuropathy prophylaxiscolorectal cancer.malignant neoplasm of colonIRCT20100127003210N15Shahid Beheshti University of Medical Sciences40
已完成
不适用
Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with RitaliIRCT201110127462N2Tehran University of Medical Sciences40
已完成
不适用
The effect of Deluxitine on the negative symptoms of schizophreniaIRCT20191218045795N2Sanandaj University of Medical Sciences44